Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

WEIGHT loss jabs could raise the risk of a “potentially blinding condition” known as an “eye stroke”, researchers have warned ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

A new study published in the JAMA Psychiatry gives the strongest evidence that semaglutide — the active ingredient in Ozempic ...

Clinical neuroscientist Joe Schacht offered an overview of the research on weight-loss drugs for alcoholism, other potential ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial of its experimental drug CagriSema — a combination of semaglutide and a ...

The maximum semaglutide dose for weight loss is 2.4 milligrams (mg) per week. Your healthcare provider will start you on a lower weekly dose and gradually increase it over time. If you’ve been ...

Wegovy is a GLP-1 agonist containing semaglutide ... weight loss after one year, and half maintained it after three years. Adults lost an average of 8% of their body weight over 56 weeks, compared ...